Chronic Kidney Disease and COVID-19: Outcomes of hospitalised adults from a tertiary care centre in North India

Bhinder, Onkar Singh; Swarnim, Swarnim; Mantan, Mukta; Dabas, Aashima; Ahlawat, Ravinder

doi:10.1016/j.mjafi.2021.12.004

Cited by 5 publications

(3 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Coronavirus disease might also influence other organs. Thus, the associated comorbidities of COVID-19 include many more chronic diseases, such as lung [ 40 ] and kidney [ 41 ] disorders. It should be noted that the long-term consequences of the infection are still not yet known; consequently, the other undesirable effects might be revealed with time.…”

Section: Introductionmentioning

confidence: 99%

Anti-Viral Surfaces in the Fight against the Spread of Coronaviruses

Kwiatkowska

Granicka

2023

Membranes

View full text Add to dashboard Cite

This review is conducted against the background of nanotechnology, which provides us with a chance to effectively combat the spread of coronaviruses, and which primarily concerns polyelectrolytes and their usability for obtaining protective function against viruses and as carriers for anti-viral agents, vaccine adjuvants, and, in particular, direct anti-viral activity. This review covers nanomembranes in the form of nano-coatings or nanoparticles built of natural or synthetic polyelectrolytes––either alone or else as nanocomposites for creating an interface with viruses. There are not a wide variety of polyelectrolytes with direct activity against SARS-CoV-2, but materials that are effective in virucidal evaluations against HIV, SARS-CoV, and MERS-CoV are taken into account as potentially active against SARS-CoV-2. Developing new approaches to materials as interfaces with viruses will continue to be relevant in the future.

show abstract

Section: Introductionmentioning

confidence: 99%

Anti-Viral Surfaces in the Fight against the Spread of Coronaviruses

Kwiatkowska

Granicka

2023

Membranes

View full text Add to dashboard Cite

show abstract

“…The article titled Chronic Kidney Disease and COVID-19: outcomes of hospitalised adults from a tertiary care centre in North India' by Bhinder et al depicted the profile and outcome of patients suffering from Chronic Kidney Disease (CKD) and COVID-19. 1 It is an undeniable fact that chronic patients are at a higher risk of contracting the disease. 2 A shorter time gap between the onset of symptom and ICU admission has also been reported previously in literature for CKD cases.…”

mentioning

confidence: 99%

“…In this paper we have shared our experience of managing adult CKD patients hospitalized with COVID 19 where majority were on maintenance hemodialysis (mHD). 1 At the outset of the pandemic there was an intense fear of the disease both amongst patients and health care staff. This led to delay and postponement of health visits in many patients but as patients on mHD need to visit dialysis centres atleast 2-3 times every week for HD most patients even in our cohort had reduced the frequency to 2 instead of 3.…”

mentioning

confidence: 99%